Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iontophoretic Dexamethasone Phosphate for Macular Edema
NCT02485249Phase 2Terminated
- Sponsor
- Kiora Pharmaceuticals
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone phosphate iontophoretic ophthalmic solution in macular edema, sponsored by Kiora Pharmaceuticals. Started Jul 2015; status: terminated.
02
Drugs
dexamethasone phosphate iontophoretic ophthalmic solution
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT02485249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485249.